Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Market Clinical Follow-Up Study for EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur With Cruciate Sacrificing Inserts

NCT04301622 is registered in ClinicalTrials.gov with MicroPort Orthopedics Inc. as lead sponsor.

NCT NCT04301622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04301622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Market Clinical Follow-Up Study for EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur With Cruciate Sacrificing Inserts
Lead sponsor
MicroPort Orthopedics Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
February 3, 2020
Completion date
August 31, 2032
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

avascular necrosis, correction of functional deformity, degenerative joint disease of knee, knee osteoarthritis, rheumatoid arthritis of knee, traumatic arthritis of knee